2 Biotechs Polish IPO Plans As Market Heats Back Up
Two biotech firms — Parkinson's disease treatment developer NeuroDerm Ltd. and gene therapy developer Xenon Pharmaceuticals Inc. — polished their initial public offering plans Monday as the market kicks back into...To view the full article, register now.
Already a subscriber? Click here to view full article